Henney FDA commissioner nomination awaiting FBI background check.
This article was originally published in The Tan Sheet
Executive Summary
HENNEY FDA COMMISSIONER NOMINATION AWAITS BACKGROUND CHECK by the FBI, which appears to be the only remaining hurdle before University of New Mexico VP-Health Sciences Jane Henney, MD, is nominated as the new FDA commissioner. The Clinton Administration has not disclosed a timetable for announcing Henney's nomination but is understood to have notified her of her selection the week of March 2. Henney, who also is president of the U.S. Pharmacopeia, was in Costa Rica until March 14 at a USP meeting.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning